Agile Therapeutics Reports Second Quarter 2016 Financial Results
08 août 2016 16h05 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Appoints Seth H. Z. Fischer to its Board of Directors
28 juil. 2016 16h11 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 28, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) today announced the appointment of Seth H. Z. Fischer to the Company's Board of Directors, effective July...
Agile Therapeutics Announces Plans to Advance Contraceptive Pipeline
12 juil. 2016 16h12 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 12, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Strengthens Executive Leadership Team with New Chief Commercial Officer
06 juil. 2016 16h15 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 06, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics Announces Issuance of Patent for Progestin Patch Designs
16 juin 2016 08h00 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics to Present at the Jefferies 2016 Healthcare Conference
02 juin 2016 17h16 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., June 02, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Reports First Quarter 2016 Financial Results
09 mai 2016 16h10 HE
|
Agile Therapeutics, Inc.
Cash Expected to Fund Operations through the End of 2017Clinical Trial Expected to Complete in Fourth Quarter 2016 and Resubmission Planned for First Half 2017 PRINCETON, N.J., May 09, 2016 ...
Agile Therapeutics to Present at Women’s Health 2016: The 24th Annual Congress
15 avr. 2016 08h00 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., April 15, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Nuvilex, Inc., Johnson & Johnson, and Medtronic, Inc., All Developing Type of Artificial Pancreas for Diabetics
02 juil. 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 2, 2013) - While Medtronic, Inc. and Johnson & Johnson are developing devices that can essentially act as a type of "artificial pancreas," Nuvilex, Inc.'s...